PDB45 CANADIAN COST UTILITY ANALYSIS COMPARING EXENATIDE VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE TWO DIABETES

Autor:	D Coyle, WJ Valentine, KS Boye, K Coyle, JB Lee, R Kisswani
Rok vydání:	2008
Předmět:	Oncology medicine.medical_specialty Cost–utility analysis Insulin glargine business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease Internal medicine Diabetes mellitus medicine In patient business Exenatide medicine.drug
Zdroj:	Value in Health. 11(3)
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)70732-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe43ecbc4e06e1cc2d02f5f9eb6bebf Zobrazit plný text záznamu Full Text from ScienceDirect Plný text